Dermapharm Holding SE
DMPHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,129,910 | $1,798,312 | $1,969,677 | $2,224,123 |
| - Cash | $171,998 | $162,686 | $115,176 | $121,195 |
| + Debt | $1,186,257 | $1,009,560 | $995,288 | $979,612 |
| Enterprise Value | $3,144,170 | $2,645,186 | $2,849,789 | $3,082,540 |
| Revenue | $346,050 | $272,146 | $302,396 | $290,670 |
| % Growth | 27.2% | -10% | 4% | – |
| Gross Profit | $126,117 | $184,131 | $199,185 | $193,179 |
| % Margin | 36.4% | 67.7% | 65.9% | 66.5% |
| EBITDA | $106,638 | $66,059 | $82,530 | $72,244 |
| % Margin | 30.8% | 24.3% | 27.3% | 24.9% |
| Net Income | $48,375 | $20,894 | $33,405 | $20,508 |
| % Margin | 14% | 7.7% | 11% | 7.1% |
| EPS Diluted | 0.9 | 0.39 | 0.62 | 0.38 |
| % Growth | 130.8% | -37.1% | 63.2% | – |
| Operating Cash Flow | $52,136 | $65,895 | $4,228 | $71,724 |
| Capital Expenditures | -$11,402 | -$10,442 | -$10,074 | -$11,879 |
| Free Cash Flow | $40,734 | $55,453 | -$5,846 | $59,845 |